UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 102

Sortiert nach

Guide de localisation des astres

Gentili, Christian

1, 2021

Link zum Volltext

Verfügbarkeit prüfen

Stereotyped distribution of midbody remnants in early C. elegans embryos requires cell death genes and is dispensable for development

Cell research, 2014-02, Vol.24 (2), p.251-253

2014

Link zum Volltext

Verfügbarkeit prüfen

Aurora A depletion reveals centrosome-independent polarization mechanism in Caenorhabditis elegans

eLife, 2019-02, Vol.8

2019

Link zum Volltext

Verfügbarkeit prüfen

Maintaining Genome Stability in Defiance of Mitotic DNA Damage

Frontiers in genetics, 2016-07, Vol.7, p.128-128

2016

Link zum Volltext

Verfügbarkeit prüfen

Chromosome Missegregation Associated with RUVBL1 Deficiency

PloS one, 2015-07, Vol.10 (7), p.e0133576-e0133576

2015

Link zum Volltext

Verfügbarkeit prüfen

Guide de localisation des astres

Christian Gentili

2008

Link zum Volltext

Verfügbarkeit prüfen

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis

Chemical science (Cambridge), 2016-08, Vol.7 (9), p.6115-6124

2016

Link zum Volltext

Verfügbarkeit prüfen

The human Exonuclease-1 interactome and phosphorylation sites

Biochemical and biophysical research communications, 2019-06, Vol.514 (3), p.567-573

2019

Link zum Volltext

Verfügbarkeit prüfen

AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion

Nature communications, 2014-05, Vol.5 (1), p.3743-3743, Article 3743

2014

Link zum Volltext

Verfügbarkeit prüfen

Sumoylation regulates EXO1 stability and processing of DNA damage

Cell cycle (Georgetown, Tex.), 2015-08, Vol.14 (15), p.2439-2450

2015

Link zum Volltext

Verfügbarkeit prüfen

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

Clinical lymphoma, myeloma and leukemia, 2024-03, Vol.24 (3), p.165-176.e4

2024

Link zum Volltext

Verfügbarkeit prüfen

P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S175

2022

Link zum Volltext

Verfügbarkeit prüfen

P-230 Pomalidomide, daratumumab, and dexamethasone after lenalidomide treatment in patients with relapsed or refractory multiple myeloma (RRMM): final overall survival analysis of the phase 2 MM-014 study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S162-S162

2023

Link zum Volltext

Verfügbarkeit prüfen

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

Scientific reports, 2019-02, Vol.9 (1), p.1335-1335, Article 1335

2019

Link zum Volltext

Verfügbarkeit prüfen

P-229: Real-world outcomes of sequencing elotuzumab (elo)-based regimens following daratumumab (dara) in patients with relapsed/refractory multiple myeloma: results from the Connect® MM Registry

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S161

2022

Link zum Volltext

Verfügbarkeit prüfen

P-232: Adverse event patterns and management with pomalidomide, dexamethasone, and daratumumab in patients with relapsed or refractory multiple myeloma: a safety analysis of the phase 2 MM-014 study

Clinical lymphoma, myeloma and leukemia, 2022-08, Vol.22, p.S162-S163

2022

Link zum Volltext

Verfügbarkeit prüfen

Dual mode of cell death upon the photo-irradiation of a Ru II polypyridyl complex in interphase or mitosis

Chemical science (Cambridge), 2016-08, Vol.7 (9), p.6115-6124

2016

Link zum Volltext

Verfügbarkeit prüfen

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosisElectronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00387g

2016-08

Link zum Volltext

Verfügbarkeit prüfen

MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S494-S495

2023

Link zum Volltext

Verfügbarkeit prüfen

POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S225-S225

2023

Link zum Volltext

Verfügbarkeit prüfen

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00387g

Chemical science (Cambridge), 2016-06, Vol.7 (9), p.6115-6124

2016

Link zum Volltext

Verfügbarkeit prüfen

Exonuclease-1 interacts with the transcriptional co-repressor KAP1

Matters, 2016-08

2016

Link zum Volltext

Verfügbarkeit prüfen

Avant-propos

Guide de localisation des astres, 2021, p.15-18

Gentili, Christian

2021

Link zum Volltext

Verfügbarkeit prüfen

Mouvement dans le repère de Frenet

Guide de localisation des astres, 2021, p.73-86

Gentili, Christian

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 102

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(44)
Mit Volltextzugriff
(96)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(25)
Humans
(16)
Life Sciences & Biomedicine
(16)
Astronomical Observation: Observatories, Equipment & Methods
(14)
Female
(8)
Male
(8)
Multidisciplinary Sciences
(6)
Science & Technology - Other Topics
(6)
Adult
(5)
Middle Aged
(5)
Treatment Outcome
(5)
Aged
(4)
Animals
(4)
Cell Biology
(4)
Clinical Neurology
(4)
Neurosciences & Neurology
(4)
Biological And Medical Sciences
(3)
Cell Cycle
(3)
Exonuclease-1
(3)
Medical Research
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Guide de localisation des astres

Stereotyped distribution of midbody remnants in early C. elegans embryos requires cell death genes and is dispensable for development

Aurora A depletion reveals centrosome-independent polarization mechanism in Caenorhabditis elegans

Maintaining Genome Stability in Defiance of Mitotic DNA Damage

Chromosome Missegregation Associated with RUVBL1 Deficiency

P882: POMALIDOMIDE, DARATUMUMAB, AND DEXAMETHASONE AFTER LENALIDOMIDE TREATMENT IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): FINAL OVERALL SURVIVAL ANALYSIS OF THE PHASE 2 MM‐014 STUDY

Guide de localisation des astres

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis

The human Exonuclease-1 interactome and phosphorylation sites

AmotL2 links VE-cadherin to contractile actin fibres necessary for aortic lumen expansion

Sumoylation regulates EXO1 stability and processing of DNA damage

Pomalidomide, Bortezomib, and Dexamethasone in Lenalidomide-Pretreated Multiple Myeloma: A Subanalysis of OPTIMISMM by Frailty and Bortezomib Dose Adjustment

P-253: Impact of adjusting bortezomib dose in the pomalidomide, bortezomib, and dexamethasone (PVd) combination: a post hoc analysis of the OPTIMISMM study

P-230 Pomalidomide, daratumumab, and dexamethasone after lenalidomide treatment in patients with relapsed or refractory multiple myeloma (RRMM): final overall survival analysis of the phase 2 MM-014 study

Pharmacophore-guided discovery of CDC25 inhibitors causing cell cycle arrest and tumor regression

P-229: Real-world outcomes of sequencing elotuzumab (elo)-based regimens following daratumumab (dara) in patients with relapsed/refractory multiple myeloma: results from the Connect® MM Registry

P-232: Adverse event patterns and management with pomalidomide, dexamethasone, and daratumumab in patients with relapsed or refractory multiple myeloma: a safety analysis of the phase 2 MM-014 study

Dual mode of cell death upon the photo-irradiation of a Ru II polypyridyl complex in interphase or mitosis

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosisElectronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00387g

MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study

POSTER: MM-371 Pomalidomide, Daratumumab, and Dexamethasone After Lenalidomide Treatment in Patients With Relapsed or Refractory Multiple Myeloma (RRMM): Final Overall Survival (OS) Analysis of the Phase II MM-014 Study

Dual mode of cell death upon the photo-irradiation of a RuII polypyridyl complex in interphase or mitosis† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c6sc00387g

Exonuclease-1 interacts with the transcriptional co-repressor KAP1

Avant-propos

Mouvement dans le repère de Frenet

Suchergebnisse filtern